Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Truvada 200mg/245mg tablets
0503010AABBAAAA
|
Truvada | Emtricitabine and tenofovir disoproxil | Infections | 16 |
|
Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
0503010AAAAAAAA
|
Emtricitabine/tenofovir disoproxil | Emtricitabine and tenofovir disoproxil | Infections | 10 |
|
Ictastan 200mg/245mg tablets
0503010AABCAAAA
|
Ictastan | Emtricitabine and tenofovir disoproxil | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.